Close Menu
    What's Hot
    Lane Clark & Peacock

    2025 Delivers Record Number of Bulk Purchase Annuity Buy-Ins in UK Pension Risk Transfer Market

    March 30, 2026
    Just Group

    Reebok UK Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With M&G

    March 30, 2026

    Athora Group Completes Acquisition of Pension Insurance Corporation

    March 30, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Tailwinds and Structural Strength Support Sustainable — If Moderating — US Life & Annuity Market Growth

      November 12, 2025

      US Annuity Sales Set Yet Another Quarterly Sales Record in Third Quarter of 2025

      October 30, 2025

      EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

      March 25, 2026

      US Individual Life Insurance New Premium To Set New Sales Record in 2025

      March 4, 2026

      US Life Insurers’ Ample Capital, Liquidity to Support Ratings in 2026

      February 25, 2026

      Higher Sales and Lower Lapse Counts but Rising Exit Values for US Life Insurance Market

      February 11, 2026
      Lane Clark & Peacock

      2025 Delivers Record Number of Bulk Purchase Annuity Buy-Ins in UK Pension Risk Transfer Market

      March 30, 2026
      Just Group

      Reebok UK Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With M&G

      March 30, 2026

      Athora Group Completes Acquisition of Pension Insurance Corporation

      March 30, 2026

      Panasonic UK Pension Plan Completes Bulk Purchase Annuity Transaction With M&G

      March 25, 2026

      Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

      March 25, 2026

      Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

      March 25, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      Mortality Rates Scrutiny as Excess Deaths Data Contradicts CMI

      February 11, 2026

      Q&A: Brandon Marz, Co-Founder and Chief Strategy Officer, LifeRoc Capital

      March 25, 2026

      Update in Delaware Estate Litigation Case Provides Added Clarity to Life Settlement Market

      March 11, 2026

      Regulatory Changes Abound in Offshore US Life/Annuity Sidecar Market but Macro Picture Is the Most Likely Determinant of Further Growth

      March 11, 2026

      Kosmos Management Announces Seventh Asset-Backed Securitisation

      March 5, 2026
      Lane Clark & Peacock

      2025 Delivers Record Number of Bulk Purchase Annuity Buy-Ins in UK Pension Risk Transfer Market

      March 30, 2026
      Just Group

      Reebok UK Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With M&G

      March 30, 2026

      Athora Group Completes Acquisition of Pension Insurance Corporation

      March 30, 2026

      Panasonic UK Pension Plan Completes Bulk Purchase Annuity Transaction With M&G

      March 25, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025

      Editor’s Letter – Volume 1, Issue 2, November 2025

      November 12, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    7,000 Steps Each Day Keeps the Doctor Away. But What Is the Impact on Insurers and Pensions?

    Mortality September 10, 2025By Greg Winterton
    Share
    Twitter LinkedIn Email

    The claim that walking 10,000 steps each day makes a significant difference to one’s health didn’t actually come from medical research — the general consensus is that it started as a marketing campaign in Japan in the 1960s. 

    In 1965, after the Tokyo Olympics, there was a big fitness boom in Japan. Yamasa Clock and Instrument Company created one of the first pedometers and branded it the “Manpo-kei”, which means “10,000 steps meter” in Japanese. The number 10,000 may have been chosen partly because it’s a nice round, memorable number but at the time, there wasn’t strong scientific evidence that 10,000 was a magic threshold. It was more of a catchy slogan to promote walking and health awareness. 

    It turns out that the magic number is actually 7,000. That is according to Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis, an article published in The Lancet Public Health in August. 

    The authors analysed data from over 160,000 adults and found that walking approximately 7,000 steps per day is associated with reductions in the risk of several serious health outcomes, including all-cause mortality (47% reduction), cardiovascular disease (25% reduction), cancer (6% reduction), type 2 diabetes (14% reduction), dementia (38% reduction), depression (22% reduction), and falls (28% reduction). 

    Current mortality tables do not factor in the number of steps walked each day by an individual – after all, the ability to collect this data is only fairly new, with the advent of smartphones and associated GPS tracking technology.  

    But if everyone in an insurance cohort – a defined benefit pension cohort from a pension risk transfer deal, a book of life annuity business, or even a standard whole of life insurance cohort – walked 7,000 steps a day, the mortality table would, most likely, look very different than it does now. 

    But how can pensions and insurers actually collect and use this data? And what is the reality for insurers and pensions that want to collect data – on enough people? 

    “Activity level data, including steps, can be gathered from a number of sources, including smartphones, wearable watches, patches, health related apps, etc. This data is able to be captured on any individual that grants access to their data,” said Mary Bahna-Nolan, Senior Director, Insurance Consulting & Technology at WTW.  

    “For insurance applications where there is an application process, an insurer can request access to such information which often includes both current and historical data but for a pension scheme or business that covers a group cohort, it becomes more challenging to obtain the data on a sufficient number of individuals – at least, today.” 

    There are people – likely plenty of them – that do monitor their daily number of steps; smartphones now come with built-in apps which provide this information at no charge. As with any new or emerging technology, there are teething issues, but patterns will emerge eventually. 

    “Different devices and how an individual uses them, wears them, etc. can provide different measurable data. Over the course of time, however, consistency in patterns of activity will likely be the similar to use in certain scoring models and measures. In addition, the technology for capturing and monitoring activity and inactivity levels continues to improve and thus, so should the reliability of the data itself. In addition, the models, as they obtain more data points, will become better calibrated to a particular population,” said Bahna-Nolan. 

    Whether or when insurance and pension cohorts get to a place where most of their cohorts are doing their 7,000 steps is up for debate; after all, an article from The Lancet Global Health just a year ago, based on physical activity reported by adults (aged ≥18 years) in population-based surveys, suggests that insufficient physical activity increased in people aged 60 years and older in all regions and both sexes. 

    So, is there realistically anything for pensions and insurers to be worried about in terms of their mortality models underestimating the extent to which people are walking 7,000 steps per day – and therefore, their mortality profile? 

    “Behavioural change is slow and often linked to educational background. Insurers already use a wide range of proxy variables such as income, education and postal code, to gauge likely good or bad health behaviours and willingness to change. As such the study will not cause immediate concern for those pricing individual annuities or group annuity policies,” said Steven Baxter, Chief Data Scientist at Club Vita. 

    “That said, we are aware of several insurers who are actively assessing the practicalities of using step count data to improve their approach to understanding the mortality or longevity risk of policyholders and form part of underwriting. These organisations will no doubt be reading this study with interest.” 

    Indeed, a recent study by WTW found that wearable-driven mortality modelling does improve underwriting accuracy and while there are many challenges for pensions or insurers to get accurate step count data – and enough of it – for inclusion in a model, you have to start somewhere. 

    “For any insurance use, it is important that insurers and pensions perform feasibility studies to understand the data and how to best calibrate it to their target population; indeed, we only recommend incorporating such data into key decision making after careful study and analysis of the implications on specific use cases,” said Bahna-Nolan. 

    “But this is an area that will continue to emerge over time, but we can’t understand the implications and opportunities if we don’t start collecting the information and measuring the outcomes.” 

    2025 - September Clinical Mortality Mortality Risk Volume 4 Issue 9 – September 2025
    Share. Twitter LinkedIn Email

    Related Posts

    Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

    March 25, 2026By Mark McCord

    Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

    March 25, 2026By Greg Winterton

    US Life Insurers’ Ample Capital, Liquidity to Support Ratings in 2026

    February 25, 2026By Jamie Tucker and Jack Rosen

    Higher Sales and Lower Lapse Counts but Rising Exit Values for US Life Insurance Market

    February 11, 2026By Roger Lawrence
    Latest Issue

    Update in Delaware Estate Litigation Case Provides Added Clarity to Life Settlement Market

    March 11, 2026

    Longevity Swap Activity Expected to Rise as Run-Ons Look More Attractive

    March 11, 2026

    Regulatory Changes Abound in Offshore US Life/Annuity Sidecar Market but Macro Picture Is the Most Likely Determinant of Further Growth

    March 11, 2026

    Defined Benefit Pension Fund Investment Strategies in Focus Amid Gilts-Linked Pension Risk Transfer Pricing

    February 25, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.